Also, a comprehensive analysis by Gibson & Kimball (2021) commentary reveals a critical finding, as the article does not contain or discuss any data related to the serological inflammatory markers CRP or ESR in the context of adalimumab treatment for hidradenitis suppurativa [19]. This evidence concerns the gene CRP and hidradenitis suppurativa.